Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer

Clinical trial NCT07102940 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07102940
Sponsor: George Washington University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer HER 2 Negative Breast Cancer HR Positive/HER-2 Negative Breast Cancer Stage 1-3

Start date: 2026-09-01
Primary completion: 2028-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.